Advertisement

VEEV

Veeva Systems Inc.

Healthcare · USD

Set alert

Price alert · VEEV

All alert types
312.96 USD +2.62 +0.84%
As of Oct 30, 2026 Extended hours 312.00 -0.31%
Bid
312.83 × 100
Ask
313.23 × 100
309.42 Day range 314.50
151.43 52-week range 323.04
YTD
+40.20%
1 year
+9.80%
Open
312.06
Prev close
310.34
Mkt cap
50.67B
Vol
1.38M
Avg vol
1.70M
EPS
6.10
P/E
51.30
Div yield
0.00%
More statistics
Low
309.42
High
314.50
Forward P/E
30.51
Beta
0.93
Short ratio
2.59
Inst. own
93.21%
Dividend
0.00
Ex-div date
Earnings
Nov 25, 2026
50-d avg
282.61
200-d avg
208.76
1y target
301.11

5D chart

Chart tools
Interval
VEEV five-day price chart306.5311.3316.2321.0325.9Oct 26Oct 27Oct 28Oct 29Oct 30

Key statistics

Market cap
50.67B
Enterprise value
43.16B
Trailing P/E
51.30
Forward P/E
30.51
PEG ratio
1.20
Price / sales
14.65
Price / book
6.82
EPS (TTM)
6.10
Beta
0.93
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
29.34%
Revenue (TTM)
3.46B
Revenue growth
17.60%
Free cash flow
1.26B
Total cash
7.24B
Total debt
151.70M
Return on equity
14.42%
Shares outstanding
161.91M
Short % of float
2.84%
50-day average
282.61
200-day average
208.76

Analyst view

Consensus: buy

Buy
Price target (mean) 301.11 -3.8% downside
Target (low)
180.00
Target (mean)
301.11
Target (high)
375.00
Ratings (0m) 29 20 buy · 8 hold · 1 sell
  • Strong buy7
  • Buy13
  • Hold8
  • Sell1
  • Strong sell0

Next earnings

Nov 25, 2026

Expected Nov 25, 2026. Consensus EPS estimate 2.34.

Earnings history

Financials — quick view

All financials
VEEV Revenue — quarterly 927.96M
2023-Q3 20222023-Q4 20222024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20232025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20242026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20252027-Q1 20262027-Q2 2026
VEEV Net income — quarterly 273.43M
2023-Q3 20222023-Q4 20222024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20232025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20242026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20252027-Q1 20262027-Q2 2026
VEEV EPS — quarterly 1.68
2023-Q3 20222023-Q4 20222024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20232025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20242026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20252027-Q1 20262027-Q2 2026

Earnings

VEEV recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 25, 2026Oct 31, 20262.33———
Aug 26, 2026Jul 31, 20262.232.35+0.12+5.38%
Jun 3, 2026Apr 30, 20262.142.24+0.10+4.67%
Mar 4, 2026Jan 31, 20261.942.06+0.12+6.19%
Nov 20, 2025Oct 31, 20251.952.04+0.09+4.62%
Aug 27, 2025Jul 31, 20251.901.99+0.09+4.74%

Upgrades / downgrades

VEEV analyst upgrades and downgrades
DateFirmActionFromTo
Oct 28, 2026BarclaysmainOverweightOverweight
Oct 26, 2026BairdmainOutperformOutperform
Oct 19, 2026BarclaysmainOverweightOverweight
Aug 28, 2026CitigroupmainNeutralNeutral
Aug 27, 2026MizuhomainOutperformOutperform
Aug 27, 2026BMO CapitalmainMarket PerformMarket Perform

About Veeva Systems Inc.

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Sector
Healthcare
Industry
Health Information Services
Country
United States
Website
veeva.com

News

Your note

Sign in to keep a note on VEEV — it syncs with the Stock Master app.

Insider holders

VEEV insider holders
InsiderRelationLatest transactionDateShares held
CARGES MARK TDirectorConversion of Exercise of derivative securityAug 31, 202613,446
FADDIS JONATHAN WGeneral CounselStock GiftOct 1, 20269,328
HEDLEY MARY LYNNEDirectorConversion of Exercise of derivative securityAug 31, 20267,629
RITTER GORDONDirectorConversion of Exercise of derivative securityAug 31, 2026934,297
RIZZO DANIEL JOfficerSaleOct 1, 20267,665
SCHWENGER THOMAS DPresidentConversion of Exercise of derivative securitySep 30, 202620,084

Institution ownership

VEEV institution ownership
Holder% heldSharesValueReported
Blackrock Inc.7.94%12,862,5034.03BJun 29, 2026
Vanguard Capital Management LLC5.99%9,692,8623.03BJun 29, 2026
Vanguard Portfolio Management LLC4.58%7,414,7432.32BJun 29, 2026
State Street Corporation4.14%6,706,9092.10BJun 29, 2026
Principal Financial Group, Inc.3.08%4,979,2101.56BJun 29, 2026
Alliancebernstein L.P.3.03%4,913,3221.54BJun 29, 2026

Fund ownership

VEEV fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.88%4,660,8471.46BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.40%3,890,3141.22BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund1.96%3,180,762995.45MJun 29, 2026
Principal Funds, Inc-MidCap Fund1.78%2,875,695899.98MJul 30, 2026
iShares Trust-iShares Core S&P 500 ETF1.23%1,991,673623.31MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Growth Index Fund1.21%1,956,667612.36MJun 29, 2026
Advertisement